<a href=https://clomid.mom/>clomid in males side effects</a> GenSight Biologics, a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced UK Medicines and Healthcare Regulatory Agency MHRA acceptance of the Company s Clinical Trial Application CTA to initiate the PIONEER Phase I II study of GS030 in patients with Retinitis Pigmentosa RP